Agilent Announces Thought Leader Award to Professor Christoph Herwig
12 Setembro 2022 - 9:00AM
Business Wire
TU Wien researcher recognized for his influential work in the
digitalization of bioprocesses
Agilent Technologies Inc. (NYSE: A) today announced Christoph
Herwig has been selected to receive a prestigious Agilent Thought
Leader Award. A prominent researcher in the field of bioprocess
technology, Christoph Herwig is a Professor of Biochemical
Engineering at TU Wien, Vienna, Austria.
Prof. Herwig’s work focuses on developing end-to-end scientific
workflows in bioprocess technology. His interdisciplinary approach
aims to generate a holistic process control strategy, including
LC/MS process analytical technology (PAT) solutions to determine
critical quality attributes (CQAs) directly and in real time. His
group also concentrates on establishing "digital twins" – data-rich
virtual copies of physical processes – which, together with
continuous PAT measurements, will enable real-time state estimation
and auto-feedback control of the bioprocess.
Bioprocess digital twins are an exciting new technology that
changes how researchers do bioprocess development, process
validation, and cGMP operations. Digital twins organize bioprocess
development, can suggest experimental designs, and manage new
knowledge, which dramatically cuts process development costs and
accelerate commercialization by combining previous platform
knowledge to predict future process results. Smart, automated
bioprocessing including digital twins is becoming an important
topic within the fast-growing biopharmaceutical industry.
“I feel very honored to receive this prestigious award, and I
thank Agilent for their innovative mindset of future bioprocess
design! Moreover, I am certain that our collaboration in this
interdisciplinary field of PAT and digital twins possesses
disruptive potential to deliver high-quality, yet affordable, drugs
for the world,” said Prof. Herwig.
“It is a great pleasure to grant Prof. Herwig this Agilent
Thought Leader Award,” said Stefan Schuette, vice president and
general manager of Agilent’s Liquid Phase Separations Division and
executive sponsor of the award. “Collaborating with leading experts
on advancing bioprocessing to the next, smart, and automated level
is a great privilege. With this award, Agilent supports the
development of important innovations to help the fast-growing
biopharmaceutical industry develop new drugs faster and with higher
quality.”
The Agilent Thought Leader Award program promotes fundamental
scientific advances by contributing financial support, products,
and expertise to the research of influential thought leaders in the
life sciences, diagnostics, and chemical analysis space. To learn
more, visit the Agilent Thought Leader Award web site.
About Agilent Technologies
Agilent Technologies Inc. (NYSE: A) is a global leader in the
life sciences, diagnostics, and applied chemical markets,
delivering insight and innovation that advance the quality of life.
Agilent’s full range of solutions includes instruments, software,
services, and expertise that provide trusted answers to our
customers' most challenging questions. The company generated
revenue of $6.32 billion in fiscal 2021 and employs 17,000 people
worldwide. Information about Agilent is available at
www.agilent.com. To receive the latest Agilent news, please
subscribe to the Agilent Newsroom. Follow Agilent on LinkedIn,
Twitter, and Facebook.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220912005290/en/
Media Naomi Goumillout Agilent Technologies
+1.781.266.2819 naomi.goumillout@agilent.com
Agilent Technologies (NYSE:A)
Gráfico Histórico do Ativo
De Mar 2024 até Abr 2024
Agilent Technologies (NYSE:A)
Gráfico Histórico do Ativo
De Abr 2023 até Abr 2024